Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.

DJTh Wagener; JA Wils; TC (Tjebbe) Kok; AST Planting; ML Couvreur; B Baron

doi:10.1016/S0959-8049(01)00319-7

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.

DJTh Wagener, JA Wils, TC (Tjebbe) Kok, AST Planting, ML Couvreur, B Baron

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	648-653
Number of pages	6
Journal	European Journal of Cancer
Volume	38
DOIs	https://doi.org/10.1016/S0959-8049(01)00319-7
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0959-8049(01)00319-7

http://hdl.handle.net/1765/64591

Cite this

Wagener, DJT., Wils, JA., Kok, TC., Planting, AST., Couvreur, ML., & Baron, B. (2002). Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial. European Journal of Cancer, 38, 648-653. https://doi.org/10.1016/S0959-8049(01)00319-7

@article{e4965c7d32b049e8a6de2fc5f91f1ed5,

title = "Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.",

author = "DJTh Wagener and JA Wils and Kok, {TC (Tjebbe)} and AST Planting and ML Couvreur and B Baron",

year = "2002",

doi = "10.1016/S0959-8049(01)00319-7",

language = "Undefined/Unknown",

volume = "38",

pages = "648--653",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Wagener, DJT, Wils, JA, Kok, TC, Planting, AST, Couvreur, ML & Baron, B 2002, 'Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.', European Journal of Cancer, vol. 38, pp. 648-653. https://doi.org/10.1016/S0959-8049(01)00319-7

Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial. / Wagener, DJTh; Wils, JA; Kok, TC (Tjebbe) et al.
In: European Journal of Cancer, Vol. 38, 2002, p. 648-653.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with a-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.

AU - Wagener, DJTh

AU - Wils, JA

AU - Kok, TC (Tjebbe)

AU - Planting, AST

AU - Couvreur, ML

AU - Baron, B

PY - 2002

Y1 - 2002

U2 - 10.1016/S0959-8049(01)00319-7

DO - 10.1016/S0959-8049(01)00319-7

M3 - Article

SN - 0959-8049

VL - 38

SP - 648

EP - 653

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -